770 articles
UC Davis researchers find anxiety disorder patients have 8% less choline in key brain regions, pointing to nutrition-based treatment potential.
A landmark meta-analysis shows aerobic, combined, and HIIT training all significantly reduce ambulatory blood pressure — a stronger mortality predictor.
New POTOMAC trial data show adding durvalumab immunotherapy to standard BCG treatment significantly reduces high-risk bladder cancer recurrence.
Eric Topol and colleagues question whether blue zone longevity data is real or a statistical mirage worth rethinking.
Hidden root infections trigger chronic inflammation that disrupts insulin function — and treating them may improve metabolic health.
AI4L uses 'Audit-Driven Prompting' to generate hallucination-free, evidence-based reviews of longevity therapies like senolytics and NAD+ boosters.
A newly funded NIH study introduces improved predictive measures for a chronic heart condition, potentially reshaping clinical risk assessment.
Cannabis use is surging among adults over 65, but Stanford Medicine specialists say today's potent marijuana carries serious, underestimated health risks.
New research shows riboflavin helps tumors evade ferroptosis. A bacterial compound called roseoflavin may flip that protection off.
New research links adult weight gain to 5x higher cancer risk, while post-surgery walking cuts complications and readmission rates significantly.
A phase IIIb trial finds adding tirzepatide to standard psoriasis treatment nearly triples complete skin clearance and drives meaningful weight loss.
New research links serotonin to tinnitus worsening, with major implications for the millions taking SSRIs for depression or anxiety.
